Kinase Inhibitor Screening Displayed IALK/I as a Possible Therapeutic Biomarker for Gastric Cancer

Despite advances in cancer chemotherapy, gastric cancer (GC) continues to have high recurrence rates and poor prognosis with limited treatment options. Understanding the etiology of GC and developing more effective, less harmful therapeutic approaches are vital and urgent. Therefore, this work descr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pharmaceutics 2022-09, Vol.14 (9)
Hauptverfasser:	Mesquita, Felipe Pantoja, Souza, Pedro Filho Noronha, da Silva, Emerson Lucena, Lima, Luina Benevides, de Oliveira, Lais Lacerda Brasil, Moreira-Nunes, Caroline Aquino, Zuercher, William J, Burbano, Rommel Mario Rodríguez, de Moraes, Maria Elisabete Amaral, Montenegro, Raquel Carvalho
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological markers Cancer Drug therapy Gene expression Genetic aspects Oncology, Experimental Prognosis Stomach cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!